The complexity and pace of change in the genetic testing market creates challenges for regulatory, oversight and payment processes.
Concert offers regulatory agencies, governing bodies and industry associations a robust platform of market data and insights from experts in the market, helping them move confidently in this new and evolving space.
Governance in a Rapidly Evolving Market
The genetic testing market is enormously complex, and the pace of change is breathtaking. There are more than 75,000 genetic testing products on the market today, and 10 new ones are added each day. Most of the recent growth is in panel tests, which are increasing in both size (number of gene targets) and variety.
Effectively managing this market transformation requires access to data, insight – and ideally, foresight. Understanding where the market is now, and where it’s headed, is critical for agencies and associations seeking to establish effective policies and programs around genetic testing.
Concert Genetics can help provide exactly this insight.
Data, Reports, Consulting
Concert Genetics is uniquely positioned to support governing organizations through this transformation thanks to our comprehensive market view. We maintain an up-to-date catalog of all genetic testing products offered by all US-based, CLIA-certified laboratories, allowing us to provide timely insight into market dynamics.
If you would like to learn more about how we can provide your organization with greater insight into the genetic testing market, complete the form on this page and we will reach out to connect.
Find out more information about our solutions for Governing Organizations by filling out the form below